Engineering Next-Generation Live Biotherapeutics with Synthetic Biology

Building Innovative Medicines from Original Scientific Discoveries

Redefining Gut Burden Management for Metabolic Diseases

123

ABOUT US

Engineering Next Generation Live Biotherapeutics with Synthetic Biology


Driven by original discoveries in biochemistry and powered by synthetic biology, we engineer probiotic chassis strains and integrate design, fermentation and formulation into a closed-loop development system. Our goal is to deliver microbiome-based solutions for metabolic diseases and build an innovation platform that can be rapidly replicated and expanded across disease areas.

A first-in-class anaerobic uric acid degradation pathway designed for in situ activity in the gut
News Center
More

  • Consensus on the Man

    The 2025 consensus on the management of hyperuricemia and gout in adolescents st

  • Hyperuricemia Has Be

    According to the Chinese Multidisciplinary Expert Consensus on the Diagnosis and

  • Gout Diagnosis and T

    The Gout Diagnosis and Treatment Guidelines report that the prevalence of hyperu

  • National Health Comm

    The National Health Commission has released the Dietary Guidelines for Adults wi

  • China CDC Weekly: Ap

    An analysis published in China CDC Weekly based on GBD 2023 data shows that Chin

  • Industry Research: L

    Industry analysis shows that prescription-grade live biotherapeutic products hav

  • IQVIA: Microbiome Th

    An IQVIA white paper suggests that microbiome therapeutics are moving from early

  • European Pharmacopoe

    The European Pharmacopoeia Commission has adopted a general chapter for LBPs for

  • Asia-Pacific Experts

    Experts associated with the Asia-Pacific Microbiome Alliance published guidance

  • LBP Industry: Live B

    A Novotech white paper notes that LBPs are moving from early exploration into a

Address: Room 214, East Building, 199 Guoshoujing Road, Pudong New Area, Shanghai, China 201210 

 Contact: info@syanbio.com

Copyright 2026. All Rights Reserved. Shanghai ICP Filing No. 2026020546.

seo seo